Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.57 |
| ▸ | CTSL | P07711 | 4/20 | 0.55 |
| ▸ | CTSB | P07858 | 4/20 | 0.55 |
| ▸ | CTSS | P25774 | 4/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 10/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 9/20 | 0.53 |
| ▸ | ITGAV | P06756 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | TACR1 | P25103 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4634963 | 0.85 | CTSB (0.72) | CTSLCTSBCTSSITGB3ITGA2B | |
| SCHEMBL18623602 | 0.85 | CTSB (0.72) | CTSLCTSBCTSSITGB3ITGA2B | |
| SCHEMBL29401021 | 0.85 | CTSB (0.72) | CTSLCTSBCTSSITGB3ITGA2B | |
| SCHEMBL22764775 | 0.85 | CTSB (0.72) | CTSLCTSBCTSSITGB3ITGA2B | |
| SCHEMBL31696719 | 0.85 | CTSB (0.72) | CTSLCTSBCTSSITGB3ITGA2B | |
| SCHEMBL10420281 | 0.83 | HDAC1 (0.73) | HDAC1CTSLCTSBCTSS | |
| SCHEMBL25356314 | 0.83 | MDM4 (0.49) | HDAC1HDAC2 | |
| SCHEMBL31210307 | 0.83 | MDM4 (0.49) | HDAC1HDAC2 | |
| SCHEMBL30229488 | 0.83 | MDM4 (0.49) | HDAC1HDAC2 | |
| SCHEMBL25356318 | 0.83 | MDM4 (0.49) | HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003959-A1 | TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | Bayer AS (NO) | 2022-06-01 | — | — | EP | disclosed |